Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Ernexa Therapeutics Inc.Listing on record | BuyD (derivative) | $10.1B | ClusterFirst in 12mo | SEC | |
Ernexa Therapeutics Inc.Listing on record | BuyD (derivative) | n/a (Converted to USD in the nightly refresh) | ClusterFirst in 12mo | SEC | |
PRAECIS PHARMACEUTICALS INCListing unverified | Other | $20.2K | SEC | ||
PRAECIS PHARMACEUTICALS INCListing unverified | OtherD (derivative) | $82.5K | SEC | ||
PRAECIS PHARMACEUTICALS INCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PRAECIS PHARMACEUTICALS INCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PRAECIS PHARMACEUTICALS INCListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |